U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07192731) titled 'An International, Multi-centre, Registry-based, Phase II Study of the Treatment of LIVER-limited HepatoCellular Carcinoma (HCC) in Patients With Preserved Liver Function by IRreversible Electroporation.' on Sept. 23.
Brief Summary: Procedural data will be recorded from patients with liver lesions from hepatocellular cancer who have been assessed by an appropriately constituted MDT (or equivalent) as appropriate to receive irreversible electroporation
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Hepatocellular Carcinoma (HCC)
Liver Ablation
Liver Cancer, Adult
Intervention:
DEVICE: Irreversible Electropor...